>>3 Dividend Stocks for a Richer Retirement<< (sponsored)
Holdings Channel Holdings Channel 13F research and institutional holdings

ARQT Insider Buying

The table below summarizes the most recent ARQT insider buying information — the latest buy being $68,821.20 by Patrick J. Heron on 5/22/2025, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ARQT insider buys like these are important for investors to follow.
ARQT insider buying image
DateInsiderPriceAmount
5-22-2025
Insider Buy		 Patrick J. Heron
 $13.65
CAGR » 		$68,821.20
5,040 shares
5-15-2025
Insider Buy		 Patrick J. Heron
 $13.62
CAGR » 		$34,316.86
2,520 shares
5-14-2025
Insider Buy		 Patrick J. Heron
 $13.76
CAGR » 		$119,351.93
8,674 shares
5-9-2025
Insider Buy		 Patrick J. Heron
 $13.60
CAGR » 		$85,691.34
6,300 shares
11-30-2024
Insider Buy		 Larry Todd Edwards
See Remarks		 $7.11
CAGR » 		$7,766.86
1,093 shares
11-30-2024
Insider Buy		 Masaru Matsuda
See Remarks		 $3.28
CAGR » 		$18,542.64
5,657 shares
11-30-2024
Insider Buy		 Todd Franklin Watanabe
See Remarks		 $3.52
CAGR » 		$21,250.03
6,038 shares
3-4-2024
Insider Buy		 Patrick J. Heron
 $9.50
CAGR » 		$199,994.00
21,052 shares
12-1-2023
Insider Buy		 Todd Franklin Watanabe
See Remarks		 $6.38
CAGR » 		$9,333.94
1,463 shares
10-24-2023
Insider Buy		 Frazier Life Sciences VIII, L.P.
>10% Owner		 $2.50
CAGR » 		$200,000.00
80,000 shares
8-5-2022
Insider Buy		 Frazier Life Sciences VIII, L.P.
>10% Owner		 $20.00
CAGR » 		$5,000,000.00
250,000 shares
10-2-2020
Insider Buy		 Jonathan Silverstein
Director and >10% Owner		 $25.00
CAGR » 		$12,400,000.00
496,000 shares
10-2-2020
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $25.00
CAGR » 		$12,400,000.00
496,000 shares
2-4-2020
Insider Buy		 Bain Capital Life Sciences Investors, LLC
>10% Owner		 $17.00
CAGR » 		$4,999,989.00
294,117 shares
2-4-2020
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $17.00
CAGR » 		$9,501,096.00
558,888 shares
2-4-2020
Insider Buy		 Jonathan Silverstein
Director and >10% Owner		 $17.00
CAGR » 		$9,501,096.00
558,888 shares
2-4-2020
Insider Buy		 Patrick J. Heron
Director and >10% Owner		 $17.00
CAGR » 		$8,500,000.00
500,000 shares
2-4-2020
Insider Buy		 Frazier Life Sciences VIII, L.P.
>10% Owner		 $17.00
CAGR » 		$8,500,000.00
500,000 shares

Also See: Institutional Holders of ARQT
Also See: SEC filings


Arcutis Biotherapeutics Insider Purchase CAGR Analysis

ARQT Performance Since Insider Purchase
Below we present the annualized performance delivered by ARQT stock since 5-22-2025 (the date of the most recent insider purchase). The performance of the investment from the time ARQT insider buying occurred is the ultimate test of whether insiders were right about ARQT being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 05/23/2025
End date: 07/10/2026
Start price/share: $13.98
End price/share: $27.74
Dividends collected/share: $0.00
Total return: 98.43%
Average Annual Total Return: 83.24%
Starting investment: $10,000.00
Ending investment: $19,843.09
Years: 1.13

Which ARQT Insiders Report Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ARQT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ARQT

ARQT Insider Buying: Recent Arcutis Biotherapeutics Purchases by Company Insiders | www.HoldingsChannel.com | Copyright © 2013 - 2026, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Holdings Channel is not affiliated with, endorsed by, or sponsored by any investment manager listed on this site. Company, fund, ETF, and investment manager names are used for identification and informational purposes only. Holdings data is based on publicly available regulatory filings and other market data sources. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.